Upstream - news in genomics
2002
Recent Advances in Genomics
Sample size: 100
publication
Evidence: high
Author Information
Author(s): Petricoin EF, Ardekani AM, Hitt BA
Conclusion
Proteomic analysis of blood samples can detect ovarian cancer, potentially even at stage I.
Supporting Evidence
- The algorithm identified a proteomic pattern that completely discriminated between cancer patients and unaffected individuals.
- The method achieved a sensitivity of 100% and a specificity of 95%.
- The analysis was based on a training set of serum samples.
Takeaway
Scientists are finding new ways to use blood tests to spot cancer early, which could help save lives.
Methodology
The study used SELDI-TOF mass spectroscopy to analyze serum proteins.
Limitations
The study's findings need further validation in larger, diverse populations.
Participant Demographics
50 ovarian cancer patients and 50 unaffected individuals.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website